Skip to content

BIONOVATE TECHNOLOGIES CORP.: 10-K filed 2016-09-27

What BIONOVATE TECHNOLOGIES CORP. reported in its annual report filed 2016-09-27 (fiscal FY 2016): 17 published measures, 55 facts as tagged in accession 0001062993-16-011567.

This filing

Form
10-K (annual report)
Filed
2016-09-27
Fiscal period
fiscal FY 2016
Accession
0001062993-16-011567 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONOVATE TECHNOLOGIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-30936USD
At 2015-06-30617USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-30151,571USD
At 2015-06-30116,938USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-30-150,635USD
At 2015-06-30-116,321USD
At 2014-06-30-82,915USD
At 2013-06-308,647USD
At 2012-06-30-14,474USD
At 2011-06-30-18,273USD
At 2010-07-18104USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-30936USD
At 2015-06-30617USD
At 2014-06-30967USD
At 2010-07-180USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2016-06-30-38,361USD366
2010-07-19 to 2016-06-30-280,133USD2174
2014-07-01 to 2015-06-30-48,204USD365
2013-07-01 to 2014-06-30-91,205USD365
2012-07-01 to 2013-06-30-87,533USD365
2011-07-01 to 2012-06-302,863USD366
2010-07-19 to 2011-06-30-17,693USD347

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-07-01 to 2016-06-30429USD366
2010-07-19 to 2016-06-30-108,950USD2174
2014-07-01 to 2015-06-30-311USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-07-01 to 2016-06-306,118USD366
2010-07-19 to 2016-06-30105,402USD2174
2014-07-01 to 2015-06-304,435USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-07-01 to 2016-06-300USD366
2010-07-19 to 2016-06-30114,188USD2174
2014-07-01 to 2015-06-300USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-280,133USD
At 2015-06-30-241,772USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-07-01 to 2016-06-300USD366
2010-07-19 to 2016-06-301,335USD2174
2014-07-01 to 2015-06-300USD365

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2016-06-3039,369USD366
2010-07-19 to 2016-06-30302,455USD2174
2014-07-01 to 2015-06-3048,886USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-07-01 to 2016-06-301,008USD366
2010-07-19 to 2016-06-3023,657USD2174
2014-07-01 to 2015-06-30682USD365

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-06-30112,195USD
At 2015-06-30112,195USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-06-3015,692USD
At 2015-06-3011,645USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-07-01 to 2016-06-30-34,314USD366
2010-07-19 to 2016-06-30-264,441USD2174
2014-07-01 to 2015-06-30-33,406USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2016-06-3019,157USD366
2010-07-19 to 2016-06-30134,838USD2174
2014-07-01 to 2015-06-3023,641USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-07-01 to 2016-06-300USD366
2010-07-19 to 2016-06-30113,806USD2174
2014-07-01 to 2015-06-300USD365

Inspect the source

Entity
BIONOVATE TECHNOLOGIES CORP. / CIK 0001575420
Captured
SEC response SHA-256
3a7f453b16552a566daef46e9f3eab08e75589223c6b3f8546d05522bd03527a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575420.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))